BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JY, Kannan B, Lim BY, Li Z, Lim AH, Loh JW, Ko TK, Ng CC, Chan JY. The Multi-Dimensional Biomarker Landscape in Cancer Immunotherapy. Int J Mol Sci 2022;23:7839. [PMID: 35887186 DOI: 10.3390/ijms23147839] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Li T, Li Y, Zhu X, He Y, Wu Y, Ying T, Xie Z. Artificial intelligence in cancer immunotherapy: Applications in neoantigen recognition, antibody design and immunotherapy response prediction. Semin Cancer Biol 2023;91:50-69. [PMID: 36870459 DOI: 10.1016/j.semcancer.2023.02.007] [Reference Citation Analysis]
2 Yap DRY, Lim JQ, Huang D, Ong CK, Chan JY. Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. Front Immunol 2023;14:1068662. [PMID: 36776886 DOI: 10.3389/fimmu.2023.1068662] [Reference Citation Analysis]
3 Zhang W, Yan Y, Peng J, Thakur A, Bai N, Yang K, Xu Z. Decoding Roles of Exosomal lncRNAs in Tumor-Immune Regulation and Therapeutic Potential. Cancers (Basel) 2022;15. [PMID: 36612282 DOI: 10.3390/cancers15010286] [Reference Citation Analysis]
4 Boudin L, Morvan JB, Thariat J, Métivier D, Marcy PY, Delarbre D. Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma. Curr Oncol 2022;29:7718-31. [PMID: 36290887 DOI: 10.3390/curroncol29100610] [Reference Citation Analysis]